telesis bio

Development of critical new vaccines and biologics with the Telesis Bio accelerates significantly.

BioXp® system; A fully automated benchtop platform for synthetic biology workflows.

We are the Authorized Distributor of Telesis Bio in Turkey.

Telesisbio Türkiye Distribütörü - Özgül Medikal
BioXp® 3250 system - BioXp® 9600 system

BioXp® 3250 system

The award-winning BioXp 3250 system accelerates discovery processes by automating the rapid synthesis of mRNA, genes, clones, and variant libraries, speeding up the 'design/build/test' cycle.

Telesis Bio Türkiye

BioXp® 9600 system

The next-generation BioXp system is designed to accelerate high-throughput screening and discovery workflows. The BioXp 9600 enables the uninterrupted, high-yield synthesis of mRNA candidates, genes, clones, and libraries overnight.

BioXp® 3250 system

BioXp® applications

Building biology in your laboratory couldn’t be easier than with the BioXp system. From creating gene fragments and clones to library construction and mRNA, BioXp applications come equipped with everything you need to complete your projects.

Create Genes
Custom high-fidelity gene fragments
Create Clones
Custom DNA fragments, up to 7,200 bp, cloned into any vector
Create libraries
Special variant DNA libraries
Create mRNA
Synthesis of up to 1,800 base-specific mRNAs
Telesis Bio ile antikor ilaç keşfi, hücre ve gen terapisi, aşı geliştirme

Get from sequence to synthesized mRNA in days, not weeks.

The BioXp platform offers an automated solution to generate purified synthetic mRNA from template DNA on demand, enabling rapid screening and validation of candidates in discovery workflows.

Telesis Bio otomatik mrna sentezi iş akışı

Sequence in, mRNA out!

BioXp® mRNA synthesis from Telesis Bio

 The BioXp® platform offers an automated, end-to-end solution to generate biologically active custom mRNA overnight, enabling you to perform rapid screening of multiple, custom mRNA variants according to your program.

 The BioXp system is designed to increase productivity, reduce turnaround time, increase yield and scale, improve quality and provide complete workflow control for both synthetic DNA and mRNA formats.

 The award-winning BioXp® 3250 system enables automated, rapid, high-throughput synthesis of genes, clones, variant libraries and mRNA, accelerating the design-build-test phases of the product development cycle.

 Enjoy the freedom to control your timelines with the BioXp system. Place BioXp application orders using our online portal and everything you need will be shipped to you within three to five days. Install the device with the provided lab supplies and press the start button. Collect your constructs the next day. It’s as simple as that.

Telesis Bio otomatik mrna sentezi iş akışı
Check Your Timelines
BioXp application orders arrive within 3 to 5 days.
Optimize Your Laboratory Budget
BioXp apps are affordable and come with everything you need
Secure Your
Intellectual Property
Make sure that your vectors never leave your laboratory.

DNA sentezinde devrim yaratıyor.

 With multiple fragments and vectors, the BioXp system can create up to 32 constructs from 300 to 7,000 base pairs in less than 21 hours. Skip plasmid preparations and synthesize transfection-ready DNA amounts of more than 8 μg. Accelerate the development of biologics and vaccines by rapidly iterating de novo gene constructs with the BioXp system.

Build better.
Build faster.
Produce cheaper.
Only in the BioXp® system.
Build better.
Build faster.
Produce cheaper.
Only in the BioXp® system.
Request DNA Index
Log in to the BioXp request portal and submit your DNA sequences
Get the Application Kit
Kits containing the fragments of your desired gene(s) arrive in 3 to 5 days
Run and Go
Load the cartridges and walk away. Your finished product can be ready in as little as six hours

The LabMedya interview with Decky Goodrich, Vice President of Commercial Operations for BioXp® Systems

Telesis Bio offers a range of advanced DNA and mRNA synthesis technologies, including the Gibson SOLA Enzymatic DNA Synthesis platform and the BioXp™ system. These platforms provide on-demand, high-accuracy DNA and mRNA synthesis and assembly for fields such as drug development, mRNA-based therapies, population genomics, and synthetic biology research. Our target audience comprises pharmaceutical and biotechnology companies, academic and research institutions, and industrial partners who require high-quality and customizable DNA and mRNA solutions to accelerate their research and product development.

For the full interview

Contact

Contact us

Contact us for your questions and cooperation requests.